Intellia's current market position is defined by the tension between its long-term technological promise and immediate safety concerns. The stock came under sustained pressure starting in late 2025 ...

This flagship smartphone delivers an impressive balance of performance, display quality, and battery power. Running on Android v15, it comes equipped with an in-display fingerprint sensor for smooth ...

Focused on CRISPR-based therapies for rare diseases and oncology, this biotech just reported a notable insider sale in public ...

Detailed price information for Intellia Thera CS (NTLA-Q) from The Globe and Mail including charting and trades.